Elizabeth Dulmes
Family · Kokomo, INNPI 1255708988
Payments from drug & device makers
Across 156 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$694
- Novo Nordisk$249
- Otsuka America Pharmaceutical, Inc.$183
- Lilly USA, LLC$160
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$158
- GSK$154
- plus $888 from 18 others
What the payments were for
- Food & beverage$2,487100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $694 |
| Novo Nordisk | 17 | $249 |
| Otsuka America Pharmaceutical, Inc. | 9 | $183 |
| Lilly USA, LLC | 10 | $160 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $158 |
| GSK | 8 | $154 |
| Dexcom, Inc. | 9 | $145 |
| Gilead | 6 | $118 |
| Supernus Pharmaceuticals, Inc. | 2 | $104 |
| Lundbeck LLC | 6 | $95 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| Ironshore Pharmaceuticals Inc. | 3 | $50 |
| Exact Sciences | 3 | $48 |
| Pfizer | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| AstraZeneca | 2 | $35 |
| Sanofi Pasteur Inc. | 2 | $30 |
| Organon | 2 | $18 |
| Boston Scientific | 1 | $15 |
| Merck | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Exeltis, USA Inc. | 1 | $14 |
| Noven Therapeutics, LLC | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
How this compares
$2,487 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 114 | $125,506 |
| MounjaroTirzepatide | 44 | $44,919 |
| EliquisApixaban | 23 | $29,301 |
| RexultiBrexpiprazole | 20 | $28,490 |
| Tresiba Flextouch U-200Insulin Degludec | 27 | $18,045 |
| TrulicityDulaglutide | 17 | $16,889 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $11,282 |
| Incruse ElliptaUmeclidinium Bromide | 18 | $8,000 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 45 | $4,515 |
| Humalog Kwikpen U-100Insulin Lispro | 13 | $3,103 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 97 | $1,739 |
| Atorvastatin Calcium | 214 | $1,617 |
| Duloxetine Hcl | 36 | $1,105 |
| Levothyroxine Sodium | 79 | $977 |
| Amlodipine Besylate | 162 | $925 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $249 | $125,506114 claims |
| Lilly USA, LLCMounjaro, Trulicity | $160 | $61,80861 claims |
| PfizerEliquis | $48 | $29,30123 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $183 | $28,49020 claims |
| GSKBreo Ellipta, Incruse Ellipta | $154 | $19,28239 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,392 family providers in Indiana.
Other family in Kokomo
- Miranda TedderKokomo$15K
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.